Travel Trouble With Legionella in the Era of COVID-19: A Case Report
| Autor: | Nuzhat T Ahmad, Didar Ul Alam, Khandakar Hussain |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Pulmonology Legionella medicine.drug_class Antibiotics Legionella Pneumonia Infectious Disease 030204 cardiovascular system & hematology Azithromycin 03 medical and health sciences 0302 clinical medicine Levofloxacin medicine Internal Medicine Intensive care medicine macrolide resistant legionella biology business.industry General Engineering legionella pneumophila biology.organism_classification medicine.disease Pneumonia covid 19 overlap syndrome Ceftriaxone business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | A 56-year-old male was admitted to the hospital with severe sepsis secondary to pneumonia. His presentation was challenging and confusing due to the accompanying coronavirus disease 2019 (COVID-19) infection attributed to his travel history and diagnosed via radiological findings. He received dexamethasone with ceftriaxone and azithromycin. Despite the fact he was on appropriate antibiotics, his condition worsened, and he was eventually diagnosed with Legionella pneumonia, which was thought to be resistant to macrolides. His condition improved significantly when antibiotics were switched to levofloxacin. It is important to keep in mind other causes of community-acquired pneumonia (CAP) during the ongoing COVID-19 era. What makes this case unique is that it presented a confusing scenario due to the patient's concurrent COVID-19 infection and his failure to improve with the administration of azithromycin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|